Title : Small molecule antagonists of the MDM2 oncoprotein as anticancer agents.

Pub. Date : 2005 Feb

PMID : 15720190






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Small molecules that have been reported to disrupt the p53-MDM2 binding, thereby enhancing p53 activity to elicit anticancer effects include the following: synthetic chalcones, norbornane derivatives, cis-imidazoline derivatives (Nutlins), a pyrazolidinedione sulfonamide and 1,4-benzodiazepine-2,5-diones, as well as tryptophan derivatives. Chalcones tumor protein p53 Homo sapiens